First Time Loading...

Pcas SA
PAR:PCA

Watchlist Manager
Pcas SA Logo
Pcas SA
PAR:PCA
Watchlist
Price: 8 EUR Market Closed
Updated: Apr 27, 2024

Wall Street
Price Targets

PCA Price Targets Summary
Pcas SA

Wall Street analysts forecast PCA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for PCA is 14.5 EUR .

Lowest
Price Target
Not Available
Average
Price Target
14.5 EUR
81% Upside
Highest
Price Target
Not Available
Pcas SA Competitors:
Price Targets
TMO
Thermo Fisher Scientific Inc
8% Upside
PIQ
Proteomics International Laboratories Ltd
29% Upside
RGEN
Repligen Corp
26% Upside
DHR
Danaher Corp
10% Upside
300030
Improve Medical Instruments Co Ltd
203% Upside
207940
Samsung Biologics Co Ltd
36% Upside
HBIO
Harvard Bioscience Inc
98% Upside
CDXS
Codexis Inc
149% Upside

Revenue
Forecast

Revenue Estimate
Pcas SA

For the last 8 years the compound annual growth rate for Pcas SA's revenue is 4%. The projected CAGR for the next 4 years is -2%.

4%
Past Growth
-2%
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Pcas SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-19%
Average Miss

Net Income
Forecast

Net Income Estimate
Pcas SA

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-32%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is PCA's stock price target?
Price Target
14.5 EUR

According to Wall Street analysts, the average 1-year price target for PCA is 14.5 EUR .

What is Pcas SA's Revenue forecast?
Projected CAGR
-2%

For the last 8 years the compound annual growth rate for Pcas SA's revenue is 4%. The projected CAGR for the next 4 years is -2%.